2015-10-13 |
1 |
|
infringement of a patent in the same family as the ’432 patent, namely U.S. Patent No. 8,586,610
(“the ’610…Page 2 of 10 PageID #: 2
U.S. Patent No. 9,138,432 (“the ’432 patent”), which relates to the field of…the ’432 patent, or any extensions thereof.
Inventia will infringe claim 1 of the ’432 patent under 35… to the methods of the ’432 patent prior to the expiration of that patent,
or any extensions thereof.…b) and (c) and
1400(b).
IV. THE PATENT-IN-SUIT – U.S. PATENT NO. 9,138,432
14. |
External link to document |
2016-10-05 |
34 |
|
Plaintiffs (Nos. 1-14) directed to U.S. Patent No. 9,138,432 filed by Taro Pharmaceutical Industries,… 13 October 2015
1:15-cv-00921
830 Patent
None
District Court, D. Delaware
|
External link to document |
2016-10-05 |
35 |
|
Plaintiffs (Nos. 1-16) directed to U.S. Patent No. 8,586,610 filed by Taro Pharmaceutical Industries,… 13 October 2015
1:15-cv-00921
830 Patent
None
District Court, D. Delaware
|
External link to document |
2016-10-10 |
38 |
|
Plaintiffs (Nos. 15-20) Directed to U.S. Patent No. 9,138,432 filed by Taro Pharmaceutical Industries,… 13 October 2015
1:15-cv-00921
830 Patent
None
District Court, D. Delaware
|
External link to document |
2016-11-04 |
50 |
|
Interrogatories to Vanda (Nos. 1-16) Directed To U.S. Patent No. 8,586,610 filed by Vanda Pharmaceuticals Inc..(Fahnestock…Interrogatories to Vanda (Nos. 1-14) Directed to U.S. Patent No. 9,138,432 and (2) Vanda's Objections and Responses… 13 October 2015
1:15-cv-00921
830 Patent
None
District Court, D. Delaware
|
External link to document |
2016-11-09 |
51 |
|
Interrogatories to Vanda (Nos. 15-20) Directed to U.S. Patent No. 9,138,432 filed by Vanda Pharmaceuticals Inc..(Fahnestock… 13 October 2015
1:15-cv-00921
830 Patent
None
District Court, D. Delaware
|
External link to document |
2017-03-09 |
60 |
|
Interrogatories to Vanda (No. 4) Directed to U.S. Patent No. 8,586,610; (2) Vanda's Supplemental Objections and…Interrogatories to Vanda (Nos. 4 and 6) Directed to U.S. Patent No. 9,138,432; and (3) Vanda's Supplemental Objections…Interrogatories to Vanda (Nos. 15, 18, 19) Directed to U.S. Patent No. 9,138,432 filed by Vanda Pharmaceuticals Inc… 13 October 2015
1:15-cv-00921
830 Patent
None
District Court, D. Delaware
|
External link to document |